REGN88 (SAR153191)

SAR153191 · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REGN88 (SAR153191), covering 2013-09-30 to 2013-09-30. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis [Phase 1]